scispace - formally typeset
K

Krista M. D. La Perle

Researcher at Ohio State University

Publications -  71
Citations -  2643

Krista M. D. La Perle is an academic researcher from Ohio State University. The author has contributed to research in topics: Thyroid & Thyroid cancer. The author has an hindex of 23, co-authored 71 publications receiving 2138 citations. Previous affiliations of Krista M. D. La Perle include Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

TL;DR: It is demonstrated that deletion of mouse Mir122 resulted in hepatosteatosis, hepatitis, and the development of tumors resembling HCC, demonstrating critical functions for miR-122 in the maintenance of liver homeostasis and have important therapeutic implications, including the potential utility of mi R-122 delivery for selected patients with HCC and the need for careful monitoring of patients receiving miR -122 inhibition therapy for HCV.
Journal ArticleDOI

Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice

TL;DR: In vitro coculture experiments suggest that nitric oxide produced by MDSC can lead to reduced IFN responsiveness in immune cells, and in vitro treatment of splenocytes with aNitric oxide donor led to a decreased STAT1 IFN response.
Journal ArticleDOI

Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas

TL;DR: It is demonstrated that the lack of functional p53 in ret/PTC1 mice promotes anaplasia and invasiveness of thyroid carcinomas.
Journal ArticleDOI

Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates.

TL;DR: The data demonstrate an effective and safe profile for systemic rAAV9-hNAGLU vector delivery in nonhuman primates, supporting its clinical potential in humans and high-level preexisting anti- AAV9 Abs lead to reduced transduction in liver and other somatic tissues, but had no detectable impact on transgene expression in the brain.